CORE
CO
nnecting
RE
positories
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Research partnership
About
About
About us
Our mission
Team
Blog
FAQs
Contact us
Community governance
Governance
Advisory Board
Board of supporters
Research network
Innovations
Our research
Labs
A phase I trial of trimetrexate glucuronate (NSC 352122) given every 3 weeks: clinical pharmacology and pharmacodynamics
Authors
B Chabner
BA Kamen
+25 more
DHW Ho
DW Fry
EA Eisenhauer
FM Balis
H Diddens
J Jolivet
JA Stewart
JC Drake
JJ Heusner
JL Grem
JR Bertino
JR Bertino
JT Lin
JT Lin
LB Grochow
M Gibaldi
M Oken
MP Fanucchi
National Cancer Institute
PA Reece
PJ O'Dwyer
RC Jackson
RC Jackson
S Legha
WM Hryniuk
Publication date
1 January 1989
Publisher
'Springer Science and Business Media LLC'
Doi
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 02/12/2020